Skip to content

Clinical trials

Phase 3 Epstein-Barr Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epstein-Barr Virus Infections Phase: Phase 3 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20142
20151
20161
20171
20192
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Unknown status3
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Friendship Hospital3
Emphasys Medical1
National Health Research Institutes, Taiwan1
Pierre Fabre Medicament1
Rong Tao1
Tessa Therapeutics1
Tobias Feuchtinger1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epstein-Barr Virus Infections9
Lymphohistiocytosis, Hemophagocytic2
Nasopharyngeal Carcinoma2
Adenoviridae Infections1
Cytomegalovirus Infections1
Emphysema1
Head and Neck Neoplasms1
Lymphoma, Extranodal NK-T-Cell1
Lymphoproliferative Disorders1
Nasopharyngeal Neoplasms1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.